Clopidogrel hyporesponsiveness and the FDA boxed warning: Detection and management of patients with genetic polymorphisms

被引:6
|
作者
Perry, Elizabeth [1 ]
机构
[1] Univ Louisiana, Monroe Coll Pharm, Shreveport, LA 71103 USA
关键词
PERCUTANEOUS CORONARY INTERVENTION; PLATELET ACTIVATION; PRASUGREL; THROMBOLYSIS; INHIBITION; COMMON;
D O I
10.2146/ajhp100422
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:529 / 532
页数:4
相关论文
共 39 条
  • [31] Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population
    Anubha Saxena
    Varinderpal S. Dhillon
    Mohammad Raish
    Mohammad Asim
    Shabeena Rehman
    N. K. Shukla
    S. V. S. Deo
    Anjum Ara
    Syed Akhtar Husain
    Breast Cancer Research and Treatment, 2009, 115 : 537 - 543
  • [32] Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population
    Saxena, Anubha
    Dhillon, Varinderpal S.
    Raish, Mohammad
    Asim, Mohammad
    Rehman, Shabeena
    Shukla, N. K.
    Deo, S. V. S.
    Ara, Anjum
    Husain, Syed Akhtar
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 115 (03) : 537 - 543
  • [33] Point-of-Care Genetic Testing of Eleven CYP2C19 Single Nucleotide Polymorphisms Identifies Extensive and Reduced Metabolizers of Clopidogrel With High Accuracy in Patients With Coronary Artery Disease
    Erlinge, David
    James, Stefan
    Duvvuru, Suman
    Jakubowski, Joseph
    Wanger, Henrik
    Varenhorst, Christoph
    Tantry, Udaya
    Brown, Patricia
    Small, David
    Moser, Brian
    Sundseth, Scott
    Walker, Joseph
    Winters, Kenneth
    Gurbel, Paul
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (17) : B211 - B212
  • [34] Prevalence of combinatorial genetic polymorphisms of CYP2C9 and VKORC1 in acute stroke patients: implications for warfarin management
    Supe, S.
    Poljakovic, Z.
    Bozina, N.
    Matijevic, V.
    Bazina, A.
    Miismas, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 167 - 167
  • [35] Genetic polymorphisms of CYP2C19*2 and ABCB1 C3435T affect the pharmacokinetic and pharmacodynamic responses to clopidogrel in 401 patients with acute coronary syndrome
    Wang, Xia-qin
    Shen, Chen-lin
    Wang, Bang-ning
    Huang, Xiao-hui
    Hu, Zhang-le
    Li, Jun
    GENE, 2015, 558 (02) : 200 - 207
  • [36] Prevalence of genetic polymorphisms of CYP2C9 and VKORC1 - Implications for warfarin management and outcome in Croatian patients with acute stroke
    Supe, Svjetlana
    Bozina, Nada
    Matijevic, Vesna
    Bazina, Antonela
    Mismas, Antonija
    Ljevak, Josip
    Alvir, Domagoj
    Habek, Mario
    Poljakovic, Zdravka
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 343 (1-2) : 30 - 35
  • [37] Genetic polymorphisms of CYP2C19*2 and ABCB1 C3435T affect the pharmacokinetics and pharmacodynamics response to clopidogrel in patients with acute coronary syndrome in the Chinese Han population
    Wang Xiaqin
    Wang Bangnin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : C127 - C128
  • [38] Analysis of genetic polymorphisms of cytochrome P450 2D6, adverse drug reactions and appropriate pharmacological management in bipolar patients with metabolic adverse effects
    La Montagna, M.
    Stella, E.
    Seripa, D.
    Miscio, G.
    Rinaldi, A.
    Bellomo, A.
    Lozupone, M.
    BIPOLAR DISORDERS, 2016, 18 : 138 - 139
  • [39] Niemann-Pick C disease:: Use of denaturing high performance liquid chromatography for the detection of NPC1 and NPC2 genetic variations and impact on management of patients and families
    Millat, G
    Baïlo, N
    Molinero, S
    Rodriguez, C
    Chikh, K
    Vanier, MT
    MOLECULAR GENETICS AND METABOLISM, 2005, 86 (1-2) : 220 - 232